Los Angeles, CANCT06361303Now EnrollingIRB Ready

Infant Death Clinical Trial in Los Angeles, CA

Access cutting-edge infant death treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.

Sponsored by Happiest Baby, Inc.

Quick Self-Assessment

See if you qualify for this Los Angeles location

Preparing your pre-screening questions…

Expert Care in Los Angeles

Access infant death specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related infant death treatment provided free

Apply for This Los Angeles Location

Check if you qualify for this infant death clinical trial in Los Angeles, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Los Angeles

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Los Angeles site if eligible
  4. 4Begin participation

About This Infant Death Study in Los Angeles

This postmarket surveillance study will evaluate the safety of the SNOO Smart Sleeper Bassinet when used for infants who are at high risk for Sudden Unexpected Infant Death (SUID). This study will survey 1000 caregivers of high-risk infants to examine the frequency of death or serious injury occurring in the SNOO Bassinet.

Sponsor: Happiest Baby, Inc.

Who Can Participate

Inclusion Criteria

Infant/caregiver dyads meeting the following inclusion criteria will be eligible for study enrollment:
Respondent must identify as a primary caregiver of the infant.
Purchase or rental of SNOO shipped to a U.S. residence during the defined enrollment period.
Caregivers must be English speakers ages 18 or older residing in the United States.
Infants must use SNOO during the intended use period (i.e., birth to 6 months).
Infants must meet at least one of the following criteria for high risk for SUID:
Infant race: Black or African American; and/or American Indian or Alaskan Native
Maternal education: 12 years or less
Low birth weight: \<5 pounds 8 ounces (\<2500 grams)
Last menstrual cycle (LMP) or obstetrical estimate (OE) Gestational age at time of birth: \<37 weeks (preterm)
Maternal age at time of birth: \<25 years
Smoking status: Any self-reported maternal smoking during pregnancy

Exclusion Criteria

Not primary caregiver
Does not speak English
Is not a US resident
Is not 18 years old or older
Infant did not use SNOO during the intended use period (i.e., birth to 6 months).
Infants does NOT meet at least one of the below risk criteria:
Infant race: Black or African American; and/or American Indian or Alaskan Native
Maternal education: 12 years or less
Low birth weight: \<5 pounds 8 ounces (\<2500 grams)
LMP or OE Gestational age at time of birth: \<37 weeks (preterm)
Maternal age at time of birth: \<25 years
Smoking status: Any self-reported maternal smoking during pregnancy

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Los Angeles?

Yes, this clinical trial (NCT06361303) has an active research site in Los Angeles, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Infant Death Treatment Options in Los Angeles, CA

If you're searching for infant death treatment options in Los Angeles, CA, this clinical trial (NCT06361303) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced infant death specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all infant death clinical trials near you to find additional studies recruiting in your area.

More Fanconi Anemia Trials in Los Angeles, CA

See all fanconi anemia clinical trials recruiting in Los Angeles — not just this study.

Browse Fanconi Anemia Trials in Los Angeles →

Browse More Trials by Condition

Fanconi Anemia TrialsAll Conditions →

Ready to Join in Los Angeles?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Los Angeles, CA